Literature DB >> 21987723

Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.

Mark J Schliekelman1, Don L Gibbons, Vitor M Faca, Chad J Creighton, Zain H Rizvi, Qing Zhang, Chee-Hong Wong, Hong Wang, Christin Ungewiss, Young-Ho Ahn, Dong-Hoon Shin, Jonathan M Kurie, Samir M Hanash.   

Abstract

The microRNA-200 (miR-200) family restricts epithelial-mesenchymal transition (EMT) and metastasis in tumor cell lines derived from mice that develop metastatic lung adenocarcinoma. To determine the mechanisms responsible for EMT and metastasis regulated by this microRNA, we conducted a global liquid chromatography/tandem mass spectrometry analysis to compare metastatic and nonmetastatic murine lung adenocarcinoma cells which had undergone EMT because of loss of miR-200. An analysis of syngeneic tumors generated by these cells identified multiple novel proteins linked to metastasis. In particular, the analysis of conditioned media, cell surface proteins, and whole-cell lysates from metastatic and nonmetastatic cells revealed large-scale modifications in the tumor microenvironment. Specific increases were documented in extracellular matrix (ECM) proteins, peptidases, and changes in distribution of cell adhesion proteins in the metastatic cell lines. Integrating proteomic data from three subproteomes, we defined constituents of a multilayer protein network that both regulated and mediated the effects of TGFβ. Lastly, we identified ECM proteins and peptidases that were directly regulated by miR-200. Taken together, our results reveal how expression of miR-200 alters the tumor microenvironment to inhibit the processes of EMT and metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987723      PMCID: PMC3419137          DOI: 10.1158/0008-5472.CAN-11-0964

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging.

Authors:  Svetlana Halfon; Natalie Abramov; Borislava Grinblat; Irene Ginis
Journal:  Stem Cells Dev       Date:  2010-10-26       Impact factor: 3.272

2.  Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.

Authors:  Christoph Roderburg; Gerd-Willem Urban; Kira Bettermann; Mihael Vucur; Henning Zimmermann; Sabine Schmidt; Jörn Janssen; Christiane Koppe; Percy Knolle; Mirco Castoldi; Frank Tacke; Christian Trautwein; Tom Luedde
Journal:  Hepatology       Date:  2010-10-01       Impact factor: 17.425

Review 3.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

4.  Eph receptor tyrosine kinases regulate astrocyte cytoskeletal rearrangement and focal adhesion formation.

Authors:  Till B Puschmann; Ann M Turnley
Journal:  J Neurochem       Date:  2010-02-25       Impact factor: 5.372

5.  The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.

Authors:  Jun Cheng; Lin Zhou; Qin-Fen Xie; Hai-Yang Xie; Xu-Yong Wei; Feng Gao; Chun-Yang Xing; Xiao Xu; Lan-Juan Li; Shu-Sen Zheng
Journal:  Proteomics       Date:  2010-04       Impact factor: 3.984

6.  The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice.

Authors:  Yanan Yang; Young-Ho Ahn; Don L Gibbons; Yi Zang; Wei Lin; Nishan Thilaganathan; Cristina A Alvarez; Daniel C Moreira; Chad J Creighton; Philip A Gregory; Gregory J Goodall; Jonathan M Kurie
Journal:  J Clin Invest       Date:  2011-03-14       Impact factor: 14.808

7.  miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.

Authors:  Gang Liu; Arnaud Friggeri; Yanping Yang; Jadranka Milosevic; Qiang Ding; Victor J Thannickal; Naftali Kaminski; Edward Abraham
Journal:  J Exp Med       Date:  2010-07-19       Impact factor: 14.307

8.  SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis.

Authors:  Ruo-Chia Tseng; Shih-Hua Lee; Han-Shui Hsu; Ben-Han Chen; Wan-Ching Tsai; Ching Tzao; Yi-Ching Wang
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

9.  Tissue-specific requirements for the proprotein convertase furin/SPC1 during embryonic turning and heart looping.

Authors:  D B Constam; E J Robertson
Journal:  Development       Date:  2000-01       Impact factor: 6.868

10.  Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Authors:  Manav Korpal; Brian J Ell; Francesca M Buffa; Toni Ibrahim; Mario A Blanco; Toni Celià-Terrassa; Laura Mercatali; Zia Khan; Hani Goodarzi; Yuling Hua; Yong Wei; Guohong Hu; Benjamin A Garcia; Jiannis Ragoussis; Dino Amadori; Adrian L Harris; Yibin Kang
Journal:  Nat Med       Date:  2011-08-07       Impact factor: 53.440

View more
  68 in total

1.  MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis.

Authors:  Stephen R Filios; Guanlan Xu; Junqin Chen; Kyunghee Hong; Gu Jing; Anath Shalev
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

Review 2.  Integration of proteomics into systems biology of cancer.

Authors:  S Hanash; M Schliekelman; Q Zhang; A Taguchi
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-03-08

Review 3.  Oxygen levels and the regulation of cell adhesion in the nervous system: a control point for morphogenesis in development, disease and evolution?

Authors:  Kathryn L Crossin
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

4.  TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression.

Authors:  Elise Bonvin; Enrico Radaelli; Martin Bizet; Flavie Luciani; Emilie Calonne; Pascale Putmans; David Nittner; Nitesh Kumar Singh; Sara Francesca Santagostino; Valérie Petit; Lionel Larue; Jean Christophe Marine; François Fuks
Journal:  Cancer Res       Date:  2018-12-11       Impact factor: 12.701

Review 5.  Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?

Authors:  Jente van Staalduinen; David Baker; Peter Ten Dijke; Hans van Dam
Journal:  Oncogene       Date:  2018-07-12       Impact factor: 9.867

6.  MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer.

Authors:  Roland Hubaux; Daiana D Becker-Santos; Katey S S Enfield; Stephen Lam; Wan L Lam; Victor D Martinez
Journal:  Metabolomics (Los Angel)       Date:  2012-03-21

Review 7.  Smoking, p53 mutation, and lung cancer.

Authors:  Don L Gibbons; Lauren A Byers; Jonathan M Kurie
Journal:  Mol Cancer Res       Date:  2014-01       Impact factor: 5.852

Review 8.  MicroRNA as tools and therapeutics in lung cancer.

Authors:  Jennifer F Barger; S Patrick Nana-Sinkam
Journal:  Respir Med       Date:  2015-02-19       Impact factor: 3.415

Review 9.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

Review 10.  The relevance of the TGF-β Paradox to EMT-MET programs.

Authors:  Chevaun D Morrison; Jenny G Parvani; William P Schiemann
Journal:  Cancer Lett       Date:  2013-03-05       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.